Orthopaedic Research Center 2017-2018 Report
Total Page:16
File Type:pdf, Size:1020Kb
ORTHOPAEDIC RESEARCH CENTER 2017-2018 REPORT MISSION TO INVESTIGATE THE PATHOGENESIS, DIAGNOSIS, TREATMENT, AND PREVENTION OF MUSCULOSKELETAL DISEASE AND INJURY FOR THE BETTERMENT OF BOTH ANIMALS AND HUMANS. PREFACE “Our principal focus continues to be solving the significant problems in equine musculoskeletal disease” It is my pleasure again to present our 2017-2018 from Colorado State University (per then President report from the Musculoskeletal Research Program Dr. Tony Frank) and $20 million from Abigail K. which consists of the Orthopaedic Research Kawananakoa and moved forward quickly from then. Center (including the Orthopaedic Bioengineering Research Laboratory), as well as, the Preclinical As I write this preface for our 2017- 2018, we have Surgical Research Laboratory and Orthopaedic settled into the TMI. It is an incredible facility that Oncology at Colorado State University. At the is providing the unique abilities for research, Orthopaedic Research Center, our principal focus education and entrepreneurial development of continues to be solving the significant problems in biologic therapies. The mission of the TMI is to equine musculoskeletal disease (as can be seen improve the lives of animals and humans through in this report) but we also continue to increase biologic therapies created via the collaborative our investigation of comparative problems and work of leading scientists and clinicians; to expedite questions relevant to human joint disease and joint the availability of these therapies, and to promote injury including techniques and devices for human education related to these goals. Our vision is, osteoarthritis and articular cartilage repair when leading the way in discovery and implementation the technique can potentially benefit the horse. of the body’s therapeutics to improve the lives The increased number of translational projects and of animals and their humans. This vision that was funding support from the National Institute of Health developed by a TMI Steering Committee led by Dr. (NIH) and human orientated industry partners support Dave Frisbie and supported by our lead donors our mission of helping both horses and humans. John and Leslie Malone and by our matching donor Abigail K. Kawananakoa has a focus on investigating As part of that evolution in June 2017 we broke the next generation remedies based on living cells ground on the new Translational Medicine Institute and their products including patient derived stem (TMI) and on the 6th of May 2019 (it might be cells to treat musculoskeletal disease and other noted that I am writing this Preface sometime ailments and to literally be able to carry basic science after the 2017-2018 years that we are reporting discoveries in the TMI all the way to bedside with on!) we moved into the TMI. As some of you will entrepreneurial and regulatory abilities within the TMI. remember, the TMI was initially described as the Institute of Biological Translational Therapies but The work and accomplishments of the excellent people were having difficulty with this name and team we developed at the Orthopaedic Research understanding what we did. In March 2016 we Center (ORC) led to this vision and the Institute. completed the matching challenge from our lead The expertise we established in analyzing and donors John and Leslie Malone of one half the developing medical treatments for animal patients, cost of the building with a $10 million commitment and then providing knowledge gained to boost 2 ORTHOPAEDIC RESEARCH CENTER human medical advancements, goes along with the with Tetrad in all aspects of the building and what concept of translational medicine and is successful we have in this remarkable facility. Dave deserves because of similarities in animal and human much credit for what we have in this facility in terms physiology and disease. The funding and building of appropriateness of what we have as he and, as of the TMI in a two- and one-half year period is mentioned previously the TMI Steering Committee truly transformational and will certainly take us to was also critical to the process. We continue to a higher level. It is also an endorsement of what evolve as a facility particularly with the large step up we have achieved already. Those achievements in continuing education (CE), and imaging, as well as have come from a combination of ingenuity and research. Achieving what we envisioned with the TMI work of our faculty, research associates, graduate is continuing to evolve with the Scientific Advisory students, veterinary students and undergraduate Board (SAB) selecting projects for support based on students as well as the critical help of our donors. their potential to find new therapies and advances. Our continued evolution has been greatly Two other major items that are critical to achieving strengthened by the addition of other principal our goals in advanced equine health are the Gail investigators and programs to the ORC and Holmes Equine Orthopaedic Research Center Orthopaedic Bioengineering including, the Preclinical transitioning to a Sports Medicine and Rehabilitation Surgical Research Laboratory led by co-directors Center under the leadership of Dr. Melissa King Jeremiah Easley and Howard Simon as well as as well as funding of phase 1 of a new Equine the programs of Drs. Steve Dow and Mike Lappin. Veterinary Teaching Hospital under the leadership These additions have brought additional talent along of, Director of Equine Clinical Services, Dr. Chris with postdoctoral researchers, graduate students Kawcak. Currently our Transitional Leadership Team and research associates. Each of our components is working carefully to evaluate what we need for continue to grow. The Orthopaedic Research Center optimal progress in the TMI. The step up in both will continue to be a major component of the TMI, but facility and management of our added programs, our other partners give us considerable strength and has been a learning curve as one continues to Reports such as this will continue to evolve as one grow, I have handed over my leadership roles and major entity. I would like to acknowledge our partners have the pleasure of looking back on 39 years of Tetrad, the developers for the building together with progress that would not have been possible without their partners Clark Ennison Architects and JE Dunn the terrific support of the faculty and staff as well the contractors. Dr. Dave Frisbie worked closely as the support of our research funders and donors. Best wishes, Wayne McIlwraith 2017-18 REPORT 3 CONTENTS Research Focuses of the Orthopaedic Research Center . 8 Musculoskeletal Research Program . 10 School of Biomedical Engineering . 12 Orthopaedic Research Center Advisory Board . 14 Editorial and Scientific Advisory Boards of ORC Faculty . 15 Donors . 16 Faculty . 23 College of Veterinary Medicine and Biomedical Science . 24 College of Engineering . 35 Post Doctoral Fellow . 37 Equine Surgery Resident . 38 Equine Sports Medicine Residents .. 39 Ph .D . Graduate Students . 41 Research Scientist . 44 Sports Medicine Manager . 45 Research Associates . 46 Administrative Staff . 49 Affiliate Faculty . 50 Collaborators . .. 53 Graduate Student Placement . 59 Surgery Residents Supervised (and Outcome) . 62 Equine Sports Medicine and Rehabilitation Residents (and Outcome) . 63 Program Synopsis . 65 History . 66 Research Activities . 67 Impact . 69 Program Trends . 70 Research Techniques Available at the Orthopaedic Research Center . 72 Research Techniques Available at the Orthopaedic Bioengineering Research Laboratory . 74 4 ORTHOPAEDIC RESEARCH CENTER 2017-2018 Scientific Publications and Presentations . 77 2018 Textbook Chapters . 78 2017 Textbook Chapters . 78 2018 Refereed Publications . 78 2017 Refereed Publications . 80 2018 Published Abstracts/Proceedings . 83 2017 Published Abstracts/Proceedings . .84 2018 Oral Presentations . 85 2017 Oral Presentations . 88 2018 Honors . 91 2017 Honors . 91 Funding, Revenue and Expenses . 93 Funded Research Projects. 94 Revenue and Expenses, FY17 • FY18 . 96 Summaries of Research Projects . 99 FOCUS 1 MUSCULOSKELETAL TISSUE HEALING Influence of changing lateral recumbency and mode of ventilation on the alveolar-arterial oxygen tension gradient and selected laboratory analysis in adult isoflurane anesthetized horses . 100 Current and novel injectable hydrogels to treat focal chondral lesions: properties and applicability . 101 Genetic modification of scAAV-equine-BMP-2 transduced bone-marrow-derived mesenchymal stem cells before and after cryopreservation: an “off-the-shelf” option for fracture repair . 103 The development and validation of a numerical integration method for non-linear viscoelastic modeling . 105 FOCUS 2 EARLY DIAGNOSIS OF BONE AND JOINT DISEASE Biomarkers for equine joint injury and osteoarthritis . 107 Biomarkers for equine joint injury and osteoarthritis: supplemental table S1 and references cited . .. 120 Incomplete fracture of the talus secondary to maladaptive stress remodeling in a horse . .. 125 The relationship between repository radiographic findings and subsequent performance of Quarter Horses competing in cutting events. 129 2017-18 REPORT 5 TABLE OF CONTENTS A coaxial dipole antenna for passively sensing object displacement and deflection for orthopaedic applications . .. 134 A comparison of arthroscopy to ultrasonography for identification of pathology of the equine stifle . 136 A comparison of arthroscopy to ultrasonography for identification of pathology of the equine stifle . 138